Vice President of Pharmaceutical Development and Business Development, WuXi AppTec
Rick joined WuXi AppTec in 2015 to provide scientific leadership for 160 scientists in developability, formulation development, GMP manufacturing and is responsible for the execution of all parenteral and oral dosage form programs. Prior to joining WuXi, Rick was Global Head of Chemical and Pharmaceutical Profiling at Novartis, where he led the development and implementation of innovative dosage form designs and continuous manufacturing paradigms. Rick has led groups in formulation, research and development at Vertex Pharmaceuticals, Symbollon Pharmaceuticals, Biogen and Baush & Lomb. In addition to his current position at WuXi, Rick is an adjunct professor at the Massachusetts College of Pharmacy.
Learn more about Rick here.